Department of Ophthalmology, Duke University School of Medicine, Durham, North Carolina, United States.
Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
Invest Ophthalmol Vis Sci. 2018 Apr 1;59(5):1969-1984. doi: 10.1167/iovs.17-23702.
Lysophosphatidic acid (LPA), a bioactive lipid, has been shown to increase resistance to aqueous humor outflow (AH) through the trabecular meshwork (TM). The molecular basis for this response of the TM to LPA, however, is not completely understood. In this study, we explored the possible involvement of mechanosensitive Yes-associated protein (YAP) and its paralog, transcriptional coactivator with PDZ-binding domain (TAZ), transcriptional activation in extracellular matrix (ECM) production by LPA-induced contractile activity in human TM cells (HTM).
The responsiveness of genes encoding LPA receptors (LPARs), LPA hydrolyzing lipid phosphate phosphatases (LPPs), and the LPA-generating autotaxin (ATX) to cyclic mechanical stretch in HTM cells, was evaluated by RT-quantitative (q)PCR. The effects of LPA and LPA receptor antagonists on actomyosin contractile activity, activation of YAP/TAZ, and levels of connective tissue growth factor (CTGF), and Cyr61 and ECM proteins in HTM cells were determined by immunoblotting, mass spectrometry, and immunofluorescence analyses.
Cyclic mechanical stretch significantly increased the expression of several types of LPARs, LPP1, and ATX in HTM cells. LPA and LPA receptor-dependent contractile activity led to increases in both, the protein levels and activation of YAP/TAZ, and increased the levels of CTGF, Cyr61, α-smooth muscle actin (α-SMA), and ECM proteins in HTM cells.
The results of this study reveal that LPA and its receptors stimulate YAP/TAZ transcriptional activity in HTM cells by modulating cellular contractile tension, and augment expression of CTGF that in turn leads to increased production of ECM. Therefore, YAP/TAZ-induced increases in CTGF and ECM production could be an important molecular mechanism underlying LPA-induced resistance to AH outflow and ocular hypertension.
溶血磷脂酸(LPA)是一种生物活性脂质,已被证明可通过小梁网(TM)增加房水流出阻力(AH)。然而,TM 对 LPA 反应的分子基础尚不完全清楚。在这项研究中,我们探讨了 LPA 诱导的收缩活性在人 TM 细胞(HTM)中产生细胞外基质(ECM)的过程中,机械敏感的 Yes 相关蛋白(YAP)及其旁系同源物、含有 PDZ 结合域的转录共激活因子(TAZ)以及转录激活是否可能参与 LPA。
通过 RT-定量(q)PCR 评估 HTM 细胞中编码 LPA 受体(LPAR)、LPA 水解脂质磷酸酶(LPP)和产生 LPA 的自分泌运动因子(ATX)的基因对周期性机械拉伸的反应性。通过免疫印迹、质谱分析和免疫荧光分析测定 LPA 和 LPA 受体拮抗剂对肌动球蛋白收缩活性、YAP/TAZ 激活以及结缔组织生长因子(CTGF)、Cyr61 和 ECM 蛋白水平的影响。
周期性机械拉伸显著增加了 HTM 细胞中几种类型的 LPAR、LPP1 和 ATX 的表达。LPA 和 LPA 受体依赖性收缩活性导致 YAP/TAZ 的蛋白水平和激活均增加,并增加了 CTGF、Cyr61、α-平滑肌肌动蛋白(α-SMA)和 ECM 蛋白在 HTM 细胞中的水平。
本研究结果表明,LPA 及其受体通过调节细胞收缩张力刺激 HTM 细胞中的 YAP/TAZ 转录活性,并增加 CTGF 的表达,进而导致 ECM 的产生增加。因此,YAP/TAZ 诱导的 CTGF 和 ECM 产生增加可能是 LPA 诱导 AH 流出阻力和眼压升高的重要分子机制。